TREML4 and atherosclerosis: In previous studies, we showed that the expression of TREML4 and its polymorphisms (rs2803495 and rs2803496) are associated with different clinical outcomes of atherosclerosis, such as coronary artery disease6, ACS7, and Coronary Artery Calcium (CAC)8.